Moritz Gerstung Profile picture
Apr 17, 2021 9 tweets 5 min read Read on X
Want to *see* how a tumour has evolved and grown? And also how different clones acquired characteristic transcriptional and histopathological features?

Hold on, that's magic.

No, it's our new preprint by @LucyYat47076319 and @MatsNilssonLab 1/9

biorxiv.org/content/10.110…
Jessica Svedlund developed a base-specific extension of the in situ sequencing protocol (BaSISS) to detect somatic mutations on a microscopy slide with fluorescently tagged padlock probes. 2/9
These signals are denoised and assembled into microscopic maps of subclonal growth using @LomakinAI's rigorous machine learning model. 3/9
The results are eye watering (for me at least) and show the record of a raging competition of breast cancer clones. The observed clonal growth tightly followed physiological tissue structures. 4/9
What’s more, layering in ISS probes targeting gene transcripts reveals each clone’s gene expression program and what type of micro environment it surrounds itself with. 5/9
Clones can also have distinct histopathological appearance, further corroborating their phenotypic divergence. 6/9
Mapping these phenotypic patterns onto the underlying phylogeny brings an order into the observed heterogeneity and reveals directional changes as a tumour progresses. 7/9
These snippets highlight the huge potential of spatial genomics and transcriptomics with BaSISS to study cancer evolution. This will enable us to measure, understand - and hopefully one day prevent - the key steps of malignant progression. 8/9
It's the result of a great research collaboration combining new technology, clinical oncology and data science. Huge thanks to Carina, Milana, @artem_shmatko, Jun, @GenomeDoctor, @stefan_seq, @vitaliikl, Vasyl, Tong, @bayraktar_lab, @luiza_moore, Sarah, Andrea and Peter. 9/9

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Moritz Gerstung

Moritz Gerstung Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @MoritzGerstung

Jan 21, 2023
There are some signs now that XBB.1.5 is loosing steam as it spreads through the wider population.

The share of cases has increased more slowly in the US and UK, recently.

A speculative thread why this might be.
In slowing down XBB.1.5 follows a pattern that has been noted also for BQ.1.1 or XBB.1.1.

Their initial fitness (daily increase of variant share) was higher than their long term advantage in a multi-lineage model with constant differences between variants (coloured lines).
In fact this slowing was observed for almost every Omicron lineage.

There is large variation between countries though, in part because of the low numbers at low incidence.

But the trends are clear that the initial growth rates dropped down on average between 0.02 to 0.04.
Read 12 tweets
Jan 3, 2023
A global look at the XBB.1.5 SARS-CoV-2 variant, which has spread rapidly in the US.
In the US its share doubled every ~8 days during the past 2.5 months and is now estimated to contribute more than 30% of cases.

Across the globe XBB.1.5 is still comparably rare (<5%).
XBB.1.5's share is rising globally, too.

However, it spreads slightly slower than in the US with relative doubling times between 8-15 days.

This makes XBB.1.5 currently the fastest spreading lineage, followed by CH.1.1.

It could possibly replace BQ.1.1.
Read 10 tweets
Nov 27, 2022
A closer look at SARS-CoV-2 variants across countries and continents:

- The competition between BQ.1*, XBB*, and BA.2.75.* inc. BN.1 & CH.1.1 remains open

- BQ.1* is more prevalent in the Western, and XBB* & BA.2.75.* in the Eastern hemisphere.
Europe and North America see high frequencies of BQ.1*.

So far there hasn’t been a major upswing of cases.

Europe saw a wave of BA.5.2 in September which stalled the spread of BQ.1*.
Parts of South America appear to see an increase of reported cases attributable to BQ.1*
Read 12 tweets
Nov 17, 2022
Some musings on SARS-CoV-2 evolution

TLDR: The share of the variant zoo increased further with BQ.1* and XBB* at the top.

But there are interesting patterns underneath which can be illustrated by one exotic lineage: CH.1.1.

It’s rare, but it rises as fast as BQ.1.1. Why? ImageImage
Background: There is a whole zoo of omicron sublineages, often defined by a range of mutations enabling partial immune escape.

Looking at the crude global increase over the past 28d CH.1.1 is one that has increased at the upper end of the flock. Image
Why does it spread as fast as BQ.1.1?

It turns out that it has independently acquired *the same set of key RBD mutations* as BQ.1.1.

Yet CH.1.1 derives from BA.2, while BQ.1.1 is a descendant of BA.5 though. Image
Read 10 tweets
Nov 4, 2022
The current SARS-CoV-2 variant situation in Germany:

* BQ.1 prevalence ranges between 5 to 12% across states,
* BQ.1.1 ranges from 5 to 15%.

The total share is around 18%. ImageImage
In line with international observations BQ.1.1’s growth advantage to other lineages is slightly lower than initial estimates suggested.

Image
Its current doubling time has come down to around 14d, also because of of competition with other lineages. Image
Read 7 tweets
Nov 4, 2022
A brief update on global SARS-CoV-2 variants:

* BQ.1.1 spreads, albeit at the low end of expectations
* XBB* and BQ* lineages are the most widespread
* Further new variants have been defined, including CK.2.1.1 leading to complex patterns
While the initial estimates of BQ.1.1's growth advantage to BA.5 were between 10-15%, the estimate has come down to ~10% more recently.

As other more transmissible variants such as BF.7 have also spread the current fitness is lower, around 6-7%.
CK.2.1.1 came a bit out of the blue but is also contributing a measurable share of cases in countries such as Spain (~9%) and Germany (~3%).

It spreads at a similar rate as BQ.1, which it also matches in terms of key RBD mutations as shown below

Read 7 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(